AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

SAj 12 Days of Holiday Cheer! Day 10: 2nd Most Viewed

Dec 22, 2019 by AMERSA

12 Days of Holiday Cheer – Celebrating Some of Our Best!

Day 10: 2nd Most Read/Viewed:

Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking

Mallika L. Mundkur, MD, MPH; Adam J. Gordon, MD, MPH; & Stefan G. Kertesz, MD, MSc

“In 2016, the Centers for Disease Control and Prevention (CDC) issued the first national guideline in the United States regarding opioid prescribing for pain.1 The guideline included the recommendation that patients treated for acute pain should receive opioids for no longer than 7 days, prompting at least 5 states to implement laws requiring prescribers not to exceed this threshold when providing initial opioid supplies.2 The rapid conversion of this guideline into policy appears to reflect an underlying assumption that limiting initial opioid supplies will reduce opioid consumption and thus addiction. However, in the spirit of “evidence-based policymaking,” we write to caution against misreading the evidence. Further, we recommend not resting addiction policy solely upon a platform of prescription opioid control.” Read the rest of the editorial now!

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!

Filed Under: SAj Blog, The Authors' Own Words, Uncategorized Tagged With: holiday, holidays

Copyright © 2025
Site by: web360